Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine as adjuvant to bupivacaine in thoracic paravertebral block for VATS postoperative analgesia
TCTR20260227006Phase 3Not yet recruiting
- Sponsor
- NA
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of morphine in postoperative pain, sponsored by NA. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
morphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on TCTR20260227006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260227006.